Danaher (DHR) Tops Q1 EPS by 20c, offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Danaher (DHR) PT Raised to $270 at BofA Securities
April 24, 2024 5:35 AM EDTBofA Securities analyst Michael Ryskin raised the price target on Danaher (NYSE: DHR) to $270.00 (from $258.00) while maintaining a Neutral rating.
The analyst comments "While DHR did not change any of its underlying assumptions for Bioprocessing in FY24, we do see continued signs... More
Deutsche Bank on Danaher (DHR): 'We expect strength in DHR stock'
April 23, 2024 8:26 AM EDTDeutsche Bank analyst Justin Bowers reiterated a Buy rating and $270.00 price target on Danaher (NYSE: DHR).
The analyst comments "We expect strength in DHR stock after a solid 1Q beat and waning sentiment into first quarter results. Danaher topped the Street and our 1Q24... More
